CCO Oncology Podcast artwork

Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations

CCO Oncology Podcast

English - January 10, 2022 18:00 - 14 minutes - 13.5 MB
Courses Education Health & Fitness Medicine essential thrombocythemia myelofibrosis oncology cme skin cancer acute myeloid leukemia kidney cancer melanoma gastrointestinal cancer prostate can Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy
Next Episode: Experts Answer Questions on Current and Emerging Options for Hemophilia A Management

In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:

Induction chemotherapy and consolidation therapyUse of gemtuzumab ozogamicinManagement of sinusoidal obstruction syndrome  Nursing considerations for younger, fit patients with AML

Presenter:

Ashley Leak Bryant, PhD, RN, OCN, FAAN
Associate Professor
School of Nursing
UNC Lineberger Comprehensive Cancer Center  
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina